MDT | tickerfilter.com

Fundamental analysis

66%

Profitability 66%

Dept financing 48%

Liquidity 25%

Performance 80%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.17%

1 Month

13.94%

3 Months

1.44%

6 Months

13.25%

1 Year

4.86%

2 Year

6.72%

Key data

Stock price

$91.69

P/E Ratio

27.09

DAY RANGE

$90.71 - $91.73

EPS

$2.31

52 WEEK RANGE

$75.96 - $93.08

52 WEEK CHANGE

$4.37

MARKET CAP

116.181 B

YIELD

3.07%

SHARES OUTSTANDING

1.282 B

DIVIDEND

$0.70

EX-DIVIDEND DATE

06/28/2024

NEXT EARNINGS DATE

N/A

BETA

0.27

PUBLIC FLOAT

AVERAGE 10 VOLUME

$6,561,812

AVERAGE 30 VOLUME

$7,752,148

Company detail

CEO: Geoffrey S. Martha
Region: US
Website: medtronic.com
Employees: 95,000
IPO year: 1981

Issue type: Common Stock
Market: NYSE
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. It operates through four segments: Cardiovascular, Neuroscience, Medical Surgical Portfolio, and Diabetes Operating Unit. The Neuroscience Portfolio segment offers products for spinal surgeons, neurosurgeons, neurologists; neurologists, pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists.

MDT - Medtronic plc